Vaccines
Safety and Immunogenicity of Pfizer-BioNTech COVID-19 Vaccine among Healthcare Workers in Lithuania
A study conducted at the Lithuanian University of Health Sciences aimed to investigate the safety and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine among healthcare workers 21 days after the first dose. Researchers analyzed data from 4,181 vaccine recipients and found that the first dose was associated with a 53.